axogen logo.jpg
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 02, 2024 16:15 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
axogen logo.jpg
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
January 18, 2024 17:00 ET | Axogen, Inc.
REPOSE® met its primary endpoint of non-inferiority between the pain visual analog scale outcomes for neurectomy with Axoguard Nerve Cap® vs. standard-of-care neurectomy at Month 12. Axoguard Nerve...
axogen logo.jpg
Axogen Announces Promotions on Research and Development Team
January 04, 2024 16:35 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) --  Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve...
axogen logo.jpg
Axogen Announces Transition of Finance Team Leadership
December 06, 2023 07:00 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
axogen logo.jpg
Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023 07:00 ET | Axogen, Inc.
ALACHUA and TAMPA, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...
Global Peripheral Nerve Repair Devices Market
Global Peripheral Nerve Repair Devices Market 2023-2028: Rising Surgical Interventions Fuel Market Growth with Abbott Laboratories, Medtronic, Stryker, and More Dominating
September 27, 2023 05:28 ET | Research and Markets
Dublin, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Peripheral Nerve Repair Devices Market (2023-2028) by Product Type, Device Type, Applications, End-Users, and Geography, Competitive Analysis,...
axogen logo.jpg
Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector™
September 05, 2023 07:00 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve...
axogen logo.jpg
Axogen to Participate at Upcoming Investor Conferences
August 31, 2023 07:00 ET | Axogen, Inc.
ALACHUA and TAMPA, Fla., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...
axogen logo.jpg
Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio
August 21, 2023 07:00 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
axogen logo.jpg
Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference
July 27, 2023 07:00 ET | Axogen, Inc.
ALACHUA and TAMPA, Fla., July 27, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...